On Dec. 12, 2007, the Breast Cancer Research Stamp Reauthorization Act extended through Dec. 31, 2011, provisions requiring…
On Nov. 27, 2007, a new National Cancer Institute (NCI) model for calculating invasive breast cancer risk, called…
On Sept. 14, 2007, the U.S. Food and Drug Administration (FDA) announced it had approved Eli Lilly’s osteoporosis…
On Apr. 20, 2007, the National Breast and Cervical Cancer Early Detection Program Reauthorization Act of 2007 allowed…
On Apr. 18, 2007, a study led by the University of Texas M.D. Anderson Cancer Center reported that…
On Mar. 28, 2007, Magnetic Resonance Imaging (MRI) scans of women who were diagnosed with cancer in one…
On Nov. 16, 2006, the U.S. Food and Drug Administration (FDA) approved Genentech’s trastuzumab (Herceptin) for use with…
On Oct. 16, 2006, the Cancer Genome Atlas program, created by National Cancer Institute and the National Human…
On Jul. 17, 2006, Eli Lilly and Company’s Gemzar was approved by the U.S. Food and Drug Administration (FDA) for…
On May 23, 2006, the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, was launched to examine…
On Apr. 17, 2006, the National Cancer Institute (NCI) announced initial results of the Study of Tamoxifen and…
In 2006, the National Cancer Institute (NCI) launched the TAILORx trial to determine whether gene expression patterns in…
On Dec. 7, 2005, results from several studies presented at the San Antonio Breast Cancer Symposium validated that…
On Nov. 11, 2005, the U.S. Congress authorized the 2-year extension of Postage Stamp for Breast Cancer Research…
On Sept. 16, 2005, preliminary results from a large, clinical trial of digital vs. film mammography showed no…
On Apr. 27, 2005, results from two large National Cancer Institute sponsored randomized clinical trials showed that patients…
On Apr. 25, 2005, the combination of the targeted agent trastuzumab (Herceptin) and standard chemotherapy cuts the risk…
On Oct. 29, 2004, the U.S. Food and Drug Administration (FDA) approved Letrozole for the extended adjuvant treatment…
In 2004, data from the Women’s Health Initiative (WHI) study show that women who take estrogen in combination…
In 2004, the world’s first use of low-dose radioactive palladium ‘seeds’ as used to treat breast cancer patients…
On Nov. 19, 2003, a novel approach to treatment of solid cancers involved therapeutic agents that inhibit the…
On Oct. 9, 2003, a Canadian-led international clinical trial found that post-menopausal survivors of early-stage breast cancer who…
On Sept. 3, 2003, the death rates from the four most common cancers, – lung, breast, prostate, and…
On Jul. 10, 2003, the University Fertility Consultants at Oregon Health & Science University (OHSU) announced they had…
In July 2003, University of Saskatchewan researchers announced they had discovered “follicular waves” in the human menstrual cycle….
On Jun. 16, 2003, researchers at Stanford University Medical Center announced they found that a drug commonly prescribed…
On Jun. 5, 2003, data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial gave fresh insight…
On Jul. 17, 2002, a National Cancer Institute funded trial showed that postmenopausal women who used estrogen replacement…
On Jul. 3, 2002, Dr. Julie Louise Gerberding, M.D., M.P.H., became the first woman Director of the U.S….
On Feb. 7, 2002, scientists from the National Cancer Institute (NCI) and the Food and Drug Administration (FDA)…